We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLU
3676
Gabelli Utility & Income Trust
GLU
$115M
$177K ﹤0.01%
10,744
-1,334
-11% -$20.1K
LUCK
3677
Lucky Strike Entertainment
LUCK
$955M
$176K ﹤0.01%
15,000
-2,038
-12% -$24.7K
BRSP
3678
BrightSpire Capital
BRSP
$683M
$176K ﹤0.01%
31,400
+21,321
+212% +$125K
VISN
3679
Vistance Networks Inc
VISN
$2.67B
$175K ﹤0.01%
28,691
+10,293
+56% +$35.3K
JPM icon
3680
PUT
JPMorgan Chase
JPM
$950B
$175K ﹤0.01%
1,000
BHC icon
3681
Bausch Health
BHC
$1.69B
$173K ﹤0.01%
21,253
-6,399
-23% -$42.2K
CHCT
3682
PUT
Community Healthcare Trust
CHCT
$543M
$173K ﹤0.01%
+9,900
New +$202K
OLPX
3683
DELISTED
Olaplex Holdings
OLPX
$172K ﹤0.01%
+73,339
New +$149K
HE icon
3684
Hawaiian Electric Industries
HE
$2.28B
$172K ﹤0.01%
17,787
-1,647
-8% -$20.4K
EVM
3685
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
$171K ﹤0.01%
17,706
HRTX icon
3686
Heron Therapeutics
HRTX
$92M
$170K ﹤0.01%
85,463
SWBI icon
3687
Smith & Wesson
SWBI
$657M
$169K ﹤0.01%
13,028
-6,043
-32% -$87.3K
SHBI icon
3688
Shore Bancshares
SHBI
$817M
$169K ﹤0.01%
12,071
+68
+0.6% +$913
WOLF icon
3689
Wolfspeed
WOLF
$1.14B
$168K ﹤0.01%
17,367
-48,188
-74% -$709K
FRBA icon
3690
First Bank
FRBA
$473M
$168K ﹤0.01%
11,020
TRTX
3691
TPG RE Finance Trust
TRTX
$660M
$167K ﹤0.01%
19,574
-3,475
-15% -$30.5K
BBAI icon
3692
BigBear.ai
BBAI
$1.32B
$167K ﹤0.01%
114,129
-1,914
-2% -$2.83K
PDT
3693
John Hancock Premium Dividend Fund
PDT
$637M
$166K ﹤0.01%
12,577
-1,815
-13% -$22.7K
DOMO icon
3694
Domo
DOMO
$170M
$164K ﹤0.01%
21,780
-1,500
-6% -$11.5K
IAUX
3695
i-80 Gold Corp
IAUX
$1.11B
$162K ﹤0.01%
139,600
-22,382
-14% -$23.5K
BTA
3696
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$162K ﹤0.01%
15,071
+77
+0.5% +$803
TWO
3697
Two Harbors Investment
TWO
$1.27B
$160K ﹤0.01%
11,533
-1,003
-8% -$13.7K
NMT icon
3698
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$131M
$155K ﹤0.01%
13,291
-2,783
-17% -$31.5K
IMNM icon
3699
Immunome
IMNM
$2.63B
$155K ﹤0.01%
+10,586
New +$150K
FLWS icon
3700
1-800-Flowers.com
FLWS
$254M
$155K ﹤0.01%
19,500
-368
-2% -$3.27K

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.